| Black Rock Coffee Bar, Inc. Reports Second Quarter 2026 Results |
Globe Newswire |
08/11 |
16:05 |
| LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights |
Globe Newswire |
08/11 |
16:05 |
| Hour Loop Reports Second Quarter of 2026 Results |
Globe Newswire |
08/11 |
16:05 |
| Inuvo Reports Second Quarter 2026 Results |
Globe Newswire |
08/11 |
16:05 |
| Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
08/11 |
16:05 |
| MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program |
Globe Newswire |
08/11 |
16:05 |
| Mobile Infrastructure Reports Second Quarter 2026 Financial Results |
Globe Newswire |
08/11 |
16:05 |
| CNB Financial Corporation Announces Quarterly Dividend for Common Stock |
Globe Newswire |
08/11 |
16:05 |
| Canterbury Park Holding Corporation Reports Second Quarter Results |
Globe Newswire |
08/11 |
16:05 |
| Snail, Inc. Reports Second Quarter 2026 Financial Results |
Globe Newswire |
08/11 |
16:05 |
| Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results |
Globe Newswire |
08/11 |
16:05 |
| SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
08/11 |
16:05 |
| Factorial Announces Second Quarter 2026 Results |
Globe Newswire |
08/11 |
16:05 |
| Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results |
Globe Newswire |
08/11 |
16:02 |
| Leonardo DRS Demonstrates Defeat of Group 1-2 Unmanned Aerial System Threats for Fielded SGT STOUT M-SHORAD |
Globe Newswire |
08/11 |
16:01 |
| Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity |
Globe Newswire |
08/11 |
16:01 |
| Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights |
Globe Newswire |
08/11 |
16:01 |
| Erasca Reports Second Quarter 2026 Business Updates and Financial Results |
Globe Newswire |
08/11 |
16:01 |
| IZEA Reports Q2 2026 Revenue of $5.8 million, Advances Enterprise-Focused Growth Strategy |
Globe Newswire |
08/11 |
16:01 |
| Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1 |
Globe Newswire |
08/11 |
16:01 |
| Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
08/11 |
16:01 |
| Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates |
Globe Newswire |
08/11 |
16:01 |
| Deadline Alert: Futu Holdings Limited (FUTU) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit |
Globe Newswire |
08/11 |
16:00 |
| Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
08/11 |
16:00 |
| ASHA Names 2026 Media Champion Award Recipients |
Globe Newswire |
08/11 |
15:58 |
